Chemfab Alkalis Ltd

Chemfab Alkalis Ltd announced that India Ratings and Research affirmed the rating of its bank loan facilities amounting to 1700 million with a rating of BBB+/Negative/IND A2, while India Ratings affirmed the rating of its bank loan facilities with an IND BBB+/Negative rating valid until October 07, 2026; the company also disclosed this intimation of credit rating under Regulation 30 of the SEBI (Listing Regulations and Disclosure Requirements) Regulations, 2015, noting that India Ratings and Research (Ind-Ra) has information on record, and India Ratings and Research Pvt Ltd reported no rating data found in the provided text. The company’s financials reveal revenue of 3,110 million in FY26 compared to 3,344 million in FY25, EBITDA of 272 million versus 437 million, an EBITDA percentage of 9% against 13%, an interest coverage of 3.5x compared to 8.9x, and a net leverage of 4.0x versus 1.4x.

CHEMFAB ALKALIS LIMITED informed the BSE Limited and National Stock Exchange of India Limited that the trading window for dealing in the company's securities will be closed for directors, designated employees, other insiders, and their relatives from October 1, 2026, until 48 hours after the announcement of the unaudited standalone and consolidated financial results for the quarter ended September 30, 2026.

CHEMFAB ALKALIS LIMITED announced that its shareholders approved the appointment of MSK C & Associates LLP (FRN. 001595S/S000168) as statutory auditors for a term of five years, commencing from the conclusion of the 17th Annual General Meeting until the conclusion of the 22nd Annual General Meeting, replacing Deloitte Haskins & Sells LLP.

CHEMFAB ALKALIS LIMITED informed the BSE Limited and National Stock Exchange of India Limited that Wednesday, September 2, 2026, has been set as the record date for determining shareholders’ eligibility to receive the final dividend for the financial year 2025–26, to be declared at the company’s 17th Annual General Meeting scheduled for Wednesday, September 9, 2026.

Net profit of Chemfab Alkalis rose 124.71% to Rs 5.73 crore in the quarter ended June 2026 as against Rs 2.55 crore during the previous quarter ended June 2025. Sales declined 20.08% to Rs 73.16 crore in the quarter ended June 2026 as against Rs 91.54 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales73.1691.54 -20 OPM %13.8512.34 - PBDT10.0011.09 -10 PBT2.224.70 -53 NP5.732.55 125 Powered by Capital Market - Live

Chemfab Alkalis will hold a meeting of the Board of Directors of the Company on 29 July 2026.

Chemfab Alkalis will hold a meeting of the Board of Directors of the Company on 29 July 2026.

Chemfab Alkalis announced that the Board of Directors of the Company at its meeting held on 13 May 2026, inter alia, have recommended the final dividend of Rs 1.25 per equity Share (i.e. 12.5%) , subject to the approval of the shareholders.

Net profit of Chemfab Alkalis reported to Rs 0.48 crore in the quarter ended March 2026 as against net loss of Rs 9.19 crore during the previous quarter ended March 2025. Sales declined 19.00% to Rs 74.78 crore in the quarter ended March 2026 as against Rs 92.32 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 3.43 crore in the year ended March 2026 as against net loss of Rs 6.94 crore during the previous year ended March 2025. Sales declined 6.98% to Rs 311.02 crore in the year ended March 2026 as against Rs 334.37 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales74.7892.32 -19 311.02334.37 -7 OPM %11.3914.44 -8.7513.08 - PBDT9.1813.15 -30 28.2245.92 -39 PBT1.232.54 -52 -0.209.58 PL NP0.48-9.19 LP -3.43-6.94 51 Powered by Capital Market - Live

Chemfab Alkalis will hold a meeting of the Board of Directors of the Company on 13 May 2026.